Related references
Note: Only part of the references are listed.Differential expression of CDC25 phosphatases splice variants in human breast cancer cells
Helene Albert et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2011)
The DNA Damage Response Pathway Regulates the Alternative Splicing of the Apoptotic Mediator Bcl-x
Lulzim Shkreta et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Cdc25B is negatively regulated by p53 through Sp1 and NF-Y transcription factors
M. Dalvai et al.
ONCOGENE (2011)
Overexpression of CDC25B, CDC25C and phospho-CDC25C (Ser216) in vulvar squamous cell carcinomas are associated with malignant features and aggressive cancer phenotypes
Zhihui Wang et al.
BMC CANCER (2010)
γH2AX: a sensitive molecular marker of DNA damage and repair
L-J Mah et al.
LEUKEMIA (2010)
Cotranscriptional exon skipping in the genotoxic stress response
Martin Dutertre et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2010)
An emerging role for nuclear RNA-mediated responses to genotoxic stress
Roberta Busa et al.
RNA BIOLOGY (2010)
DNA Damage Regulates Alternative Splicing through Inhibition of RNA Polymerase II Elongation
Manuel J. Munoz et al.
CELL (2009)
Dual Regulation of Cdc25A by Chk1 and p53-ATF3 in DNA Replication Checkpoint Control
Anastasia R. Demidova et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
The DNA-damage response in human biology and disease
Stephen P. Jackson et al.
NATURE (2009)
Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches
Mo Chen et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2009)
Cellular stress and RNA splicing
Giuseppe Biamonti et al.
TRENDS IN BIOCHEMICAL SCIENCES (2009)
Cell Cycle Control by the CDC25 Phosphatases
Bernadette Aressy et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2008)
Cyclin D1b is aberrantly regulated in response to therapeutic challenge and promotes resistance to estrogen antagonists
Ying Wang et al.
CANCER RESEARCH (2008)
Identification and characterization of a novel Mdm2 splice variant acutely induced by the chemotherapeutic agents adriamycin and actinomycin D
Nathan H. Lents et al.
CELL CYCLE (2008)
Splicing and splice factor SRp55 participate in the response to DNA damage by changing isoform ratios of target genes
Valery Filippov et al.
GENE (2008)
Overexpression of the dual specificity phosphatase, Cdc25C, confers sensitivity on tumor cells to doxorubicin-induced cell death
Shohreh Varmeh et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Alternative isoform regulation in human tissue transcriptomes
Eric T. Wang et al.
NATURE (2008)
Full-length hdmX transcripts decrease following genotoxic stress
M. Markey et al.
ONCOGENE (2008)
Differential mitotic degradation of the CDC25B phosphatase variants
I. Kieffer et al.
ONCOGENE (2007)
The early response to DNA damage can lead to activation of alternative splicing activity resulting in CD44 splice pattern changes
Valery Filippov et al.
CANCER RESEARCH (2007)
CDC25 phosphatases in cancer cells: key players? Good targets?
Rose Boutros et al.
NATURE REVIEWS CANCER (2007)
ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage
Shuhei Matsuoka et al.
SCIENCE (2007)
Alternative splicing: an emerging topic in molecular and clinical oncology
Maria J. Pajares et al.
LANCET ONCOLOGY (2007)
Genotoxic stress induces coordinately regulated alternative splicing of the p53 modulators MDM2 and MDM4
Dawn S. Chandler et al.
CANCER RESEARCH (2006)
The when and wheres of CDC25 phosphatases
R Boutros et al.
CURRENT OPINION IN CELL BIOLOGY (2006)
Cdc25: mechanisms of checkpoint inhibition and recovery
Christina Karisson-Rosenthal et al.
TRENDS IN CELL BIOLOGY (2006)
Increased expression and activity of CDC25C phosphatase and an alternatively spliced variant in prostate cancer
M Ozen et al.
CLINICAL CANCER RESEARCH (2005)
Expression and functional significance of CDC25B in human pancreatic ductal adenocarcinoma
JC Guo et al.
ONCOGENE (2004)
Cdc25 phosphatases and cancer
K Kristjánsdóttir et al.
CHEMISTRY & BIOLOGY (2004)
Arsenite-induced Cdc25C degradation is through the KEN-box and ubiquitin-proteasome pathway
F Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Differential expression of cdc25 cell-cycle-activating phosphatases in human colorectal carcinoma
S Hernández et al.
LABORATORY INVESTIGATION (2001)
Alternative splicing in the regulatory region of the human phosphatases CDC25A and CDC25C
S Wegener et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2000)